For research use only. Not for therapeutic Use.
First-in-class iodothyronine deiodinase type 3 (DIO3) inhibitor, demonstrating attenuated cell counts, induction in apoptosis, and a reduction in cell proliferation in DIO3-positive HGSOC cells (OVCAR3 and KURAMOCHI).
KEYWORDS: PBENZ-DBRMD | Supplier | DIO3 Inhibitor | CAS [1454662-41-9] | DIO3 | Deiodinase type 3 | Inhibitor | Enzymes
Catalog Number | I047678 |
CAS Number | 1454662-41-9 |
Molecular Formula | C11H5Br2NO4 |
Purity | ≥95% |
IUPAC Name | 4-(3,4-dibromo-2,5-dioxopyrrol-1-yl)benzoic acid |
InChI | InChI=1S/C11H5Br2NO4/c12-7-8(13)10(16)14(9(7)15)6-3-1-5(2-4-6)11(17)18/h1-4H,(H,17,18) |
SMILES | C1=CC(=CC=C1C(=O)O)N2C(=O)C(=C(C2=O)Br)Br |
Reference | D Moskovich et al. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene. 2021;40(44):6248-6257. |